Form 4 for WTW Willis Towers Watson
Accepted 2022-08-05 00:00:00 ET · period of report 2022-08-04 · accession 0001127602-22-020557 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-05 | 2022-08-04 | WTW | Gebauer Julie Jarecke | Head of Health, Wealth, Career | S - Sale | $210.01 | -1,400 | 92.6K | -1% | -$294.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, nominal value $0.000304635 per share | 2022-08-04 | S | D | 1,400 | $210.01 | 92,555 | D | — | — | (F1) The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. (F2) This transaction was executed in multiple trades at prices ranging from $210.00 to $210.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) Includes 1,202.036 restricted share units subject to the satisfaction of vesting requirements. |